Indivior (INDV) revenue breakdown
By product, SUBLOCADE is the largest at 58% of fiscal 2023 revenue, growing 61% a year over 2 years.
By region, US is the largest at 85% of fiscal 2025 revenue, growing 15% a year over 4 years.
Revenue by product
Fiscal years, as Indivior reports them in its 10-K filings; fiscal 2023 total $1.1B.
| Products | 2021 | 2022 | 2023 | Share |
|---|---|---|---|---|
| SUBLOCADE | $244M | $408M | $630M | 58% |
| Sublingual/Other | $530M | $465M | $421M | 39% |
| PERSERIS | $17M | $28M | $42M | 4% |
Revenue by region
Fiscal years, as Indivior reports them in its 10-K filings; fiscal 2025 total $1.2B.
| Regions | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| US | $603M | $732M | $912M | $1.0B | $1.1B | 85% |
| Rest of World | — | $169M | $181M | $179M | $186M | 15% |
| Rest of World | $181M | — | — | — | — | — |
| United Kingdom | $7M | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for INDV.
Open INDV in InvestinglyQuestions
Where does Indivior make its money?
In fiscal 2023, by product: SUBLOCADE $630M, Sublingual/Other $421M, PERSERIS $42M.
From Indivior's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.